Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Effect of curcumin intervention on radiation-induced injury: a GRADE-based systematic review and meta-analysis.

  • 2026-04-28
  • BMC cancer 26(1)
    • Litong Zhan
    • Man Qia
    • Yin Cha
    • Xiaofeng Gao

Study Design

Type
Meta-Analysis
Methods
A comprehensive systematic search of PubMed, Web of Science, Embase, Cochrane Library, CNKI, Wanfang, and VIP was conducted from inception to 2 July 2025. Risk of bias was assessed using the Cochrane RoB 2.0 tool, and certainty of evidence was evaluated using GRADE approach.
BACKGROUND: Radiation-induced injury (RII) is a common condition among patients receiving radiation therapy which affects the quality of life and clinical outcomes in cancer patients. Curcumin has shown promising therapeutic potential in the ameliorating RII through its radioprotective, anti-inflammatory and antioxidant properties. However, the findings across studies remain inconsistent. METHODS: A comprehensive systematic search of PubMed, Web of Science, Embase, Cochrane Library, CNKI, Wanfang, and VIP was conducted from inception to 2 July 2025. Risk of bias was assessed using the Cochrane RoB 2.0 tool, and certainty of evidence was evaluated using GRADE approach. RESULTS: Based on finding, curcumin significantly reduced the incidence of severe RII (RR: 0.58, 95% CI: 0.46, 0.74; P < 0.001), the score of radiation injury severity (SMD: -0.90, 95% CI: -1.25, -0.55; P < 0.001), score of pain using NRS (SMD: -7.56, 95% CI: -9.47, -5.65; P < 0.001) and VAS (SMD: -1.53, 95% CI: -2.52, -0.54; P = 0.002) and weight (SMD: -0.69, 95% CI: -1.25, -0.13; P = 0.015). However, curcumin was not associated with the incidence of overall RII (RR: 0.98, 95% CI: 0.95, 1.01; P = 0.259). CONCLUSION: The present systematic review and meta-analysis indicated that curcumin may exert promising effects in mitigating RII. It has been shown that patients with RII may benefit from curcumin treatment through reduced incidence of severe RII and score of severity and adverse events. Nevertheless, well-designed studies across multiple populations with rigorous methodologies and optimized dose regimens are warranted to establish firm conclusions.

Research Insights

Adverse Events Reported

  • Turmeric→overall radiation-induced injury

    curcumin was not associated with the incidence of overall RII (RR: 0.98, 95% CI: 0.95, 1.01; P = 0.259)

    Finding
    No significant difference
    Magnitude
    RR: 0.98, 95% CI: 0.95, 1.01; P = 0.259
    Significant
    No
  • Turmeric→pain

    score of pain using NRS (SMD: -7.56, 95% CI: -9.47, -5.65; P < 0.001) and VAS (SMD: -1.53, 95% CI: -2.52, -0.54; P = 0.002)

    Finding
    Reported
    Magnitude
    NRS: SMD: -7.56, 95% CI: -9.47, -5.65; P < 0.001; VAS: SMD: -1.53, 95% CI: -2.52, -0.54; P = 0.002
    Significant
    Yes
  • Turmeric→radiation injury severity

    the score of radiation injury severity (SMD: -0.90, 95% CI: -1.25, -0.55; P < 0.001)

    Finding
    Reported
    Magnitude
    SMD: -0.90, 95% CI: -1.25, -0.55; P < 0.001
    Significant
    Yes
  • Turmeric→severe radiation-induced injury

    curcumin significantly reduced the incidence of severe RII (RR: 0.58, 95% CI: 0.46, 0.74; P < 0.001)

    Finding
    Reported
    Grade
    severe
    Magnitude
    RR: 0.58, 95% CI: 0.46, 0.74; P < 0.001
    Significant
    Yes
  • Turmeric→weight loss

    weight (SMD: -0.69, 95% CI: -1.25, -0.13; P = 0.015)

    Finding
    Reported
    Magnitude
    SMD: -0.69, 95% CI: -1.25, -0.13; P = 0.015
    Significant
    Yes
Back to top